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Letter to the Editor 
Expanding accessibility: Outpatient intensive treatment for substance use disorder during 
covid-19 pandemic 
The COVID-19 pandemic has impacted mental health, particularly 
for people with preexisting conditions such as Substance Use Disorders 
(SUD) (Brooks et al., 2020; Volkow, 2020; Panamerican Health Orga-
nization, 2016). 
Since 2010, our team has provided outpatient intensive treatment for 
people with SUDs. Our therapeutic program includes group and indi-
vidual psychotherapy, workshops (meditation, physical activity, nutri-
tional advice, smoking cessation, yoga), weekly meetings with the 
patient’s social support network, and psychiatric and clinical evalua-
tions. In the context of the COVID-19 pandemic, we migrated all services 
to a remote-enabled mode through a videoconference platform, 
including group and individual meetings. The frequency of groups was 
increased after the lockdown from 4 times a week to daily. 
As part of an ongoing research project approved by the Ethical 
Committee of the School of Medicine of the University of Buenos Aires 
(08-05-2019), we compared adherence to treatment immediately before 
the beginning of the lockdown (T1-Adh) with that observed 3 months 
later (T2-Adh), using an 11 point scale (i.e. 0=absence of adherence and 
10=the best performance). A single score for each patient at each time 
point was derived based upon two parameters: attendance at activities, 
and compliance (which included three items: use of a protocol agreed 
upon at the beginning of treatment, consistent use of an agenda together 
with cell phone applications to register sober time and general well-
being, and compliance with other indications such as pharmacological 
treatment if prescribed). Alcohol and drug use were evaluated with the 
5th version of the Addiction Severity Index (ASI) (Mclellan et al., 1992), 
comparing scores obtained at the time of admission to treatment 
(T0-alcohol or T0-drugs) to those measured immediately before the 
beginning of lockdown (T1-alcohol and T1-drugs) and three months 
later (T2-alcohol and T2-drugs). The table summarizes the main de-
mographic data of the 19 patients included in this report (Table 1). 
There was no significant change over time in adherence scores (mean 
± SD): T1-Adh: 8 ± 1.9 vs T2-Adh: 8 ± 1.4 (p = n.s.; Wilcoxon matched 
paired test, N = 19). ASI scores (mean ± SD) for alcohol and drug 
consumption improved over time: T0-alcohol: 0.30 ± 0.3; T1-alcohol 
0.06 ± 0.12; T2-alcohol 0.02 ± 0.05 r (p < 0.001, Kruskal Wallis fol-
lowed by Dunn’s test; N = 19); T0-drugs 0.12 ± 0.1; T1-drugs 0.03 ±
0.05 and T2-drugs 0.001 ± 0.005 (p < 0.001; Kruskal Wallis followed by 
Dunn’s test; N = 19). A slight increment in the drop-out/new admissions 
ratio was observed due to a decrement in admissions rather than an 
increment in drop-outs in the five months that elapsed after the 
pandemic onset, in comparison with a similar previous period (5/17 vs 
5/20 respectively). 
These preliminary results suggest that a remotely-provided intensive 
outpatient treatment for people with SUD is as effective as a face-to-face 
ambulatory intensive approach, under the current extraordinary cir-
cumstances. However, it should be emphasized that the therapeutic 
team suffered significantly higher stress and work overload under these 
circumstances. To address this, in addition to the usual team meetings 
and clinical supervision, team members attended mutual support group 
meetings aimed at detecting individual cases of emotional distress, and 
providing support. According to our experience, sustaining outpatient 
programs during times of crisis such as the COVID-19 pandemic is not 
only possible, but necessary. 
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Table 1 
Demographic data (n = 19).  
Male subjects (n) 13 
Age (years) (mean ± SD) 44 ± 16 
Education (years) (mean ± SD) 17 ± 3 
Main substance consumed (n)  
Alcohol 6 
Cocaine 7 
Two or more (cannabis/alcohol/cocaine) 6  
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